Patents by Inventor Gautam K. Bandyopadhyay

Gautam K. Bandyopadhyay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A PEPTIDE THERAPY TO COUNTERACT INSULIN RESISTANCE AND TYPE 2 DIABETES
    Publication number: 20170209544
    Abstract: Compositions comprising an antagonist of pancreastatin are provided. The beneficial use of the compositions for treating insulin resistance, diabetes, especially type II diabetes, inflammation, obesity, non-alcoholic fatty liver disease, atherosclerosis and cardiovascular diseases is described as well.
    Type: Application
    Filed: July 15, 2015
    Publication date: July 27, 2017
    Inventors: Sushil K. Mahata, Gautam K. Bandyopadhyay, Sanjib Senapati
  • Methods for promoting lipolysis and oxidation in liver and adipose tissue using catestatin
    Patent number: 9572862
    Abstract: The invention provides methods for treating obesity in a subject comprising administering an effective amount of catestatin (CST) or its equivalent to a subject afflicted with obesity so as to maintain an effective amount of circulating catestatin in the subject to promote lipolysis and oxidation of released fatty acids in both liver and adipose tissue, thereby, reducing adipose tissue weight and hence treating obesity in the afflicted subject.
    Type: Grant
    Filed: April 1, 2013
    Date of Patent: February 21, 2017
    Assignee: The Regents of the University of California
    Inventors: Sushil K. Mahata, Gautam K. Bandyopadhyay
  • METHODS FOR PROMOTING LIPOLYSIS AND OXIDATION IN LIVER AND ADIPOSE TISSUE USING CATESTATIN
    Publication number: 20150080294
    Abstract: The invention provides methods for treating obesity in a subject comprising administering an effective amount of catestatin (CST) or its equivalent to a subject afflicted with obesity so as to maintain an effective amount of circulating catestatin in the subject to promote lipolysis and oxidation of released fatty acids in both liver and adipose tissue, thereby, reducing adipose tissue weight and hence treating obesity in the afflicted subject.
    Type: Application
    Filed: April 1, 2013
    Publication date: March 19, 2015
    Inventors: Sushil K. Mahata, Gautam K. Bandyopadhyay